LAB
NEWS
March
1995 . . . . . . . . . . Vol. 37 No. 1
Chairman:
Peter Jatlow,
M.D.
Editors: Edward L. Snyder, M.D.; Petrie M. Rainey, M.D.,
Ph.D.
Production Assistant: Terri M. Fiondella
Contributors: Peter McPhedran, M.D.; Steve Mechanic, M.D.;
Brian Smith, M.D.; Petrie Rainey, M.D.
RED
CELL MORPHOLOGY REPORTING - CHANGES IN PROGRESS
Evaluation
of a stained peripheral blood smear is often useful in the diagnosis
of a wide variety of malignant, infectious, or genetic illnesses.
Evaluation of red cell morphology is usually done as part of blood
smear evaluation, and is often helpful in identifying the cause of
anemia. A large number of red cell characteristics are assessed, which
can be grouped under several headings: variations of red cell size,
color, shape, inclusions, and association. There is an especially
long list of terms available for the description of shape changes.
Reported abnormalities are often semi-quantitated ("1+, 2+, etc").
Some abnormal morphologic features are relatively specific and diagnostic,
while others are vague, and can be confusing.
It was customary in our lab, and most other hematology laboratories,
for the technologist to report every morphologic deviation seen,
whether significant or not. Thus, occasional truly diagnostic blood
smear characteristics are sometimes obfuscated by the concurrent
reporting of non-specific findings and even normal variants. The
term that would point to the diagnosis may even be omitted in favor
of one that is non-specific: marked spherocytosis may be called
"anisocytosis". Finally, technologists have traditionally
reported findings rather than diagnoses, expecting
the physician to interpret correctly the significance of reported
morphologic abnormalities.
We thought the system did not work well, and we changed it. Starting
in 1/94, we modified our red cell morphology reporting so that:
- only
abnormal findings would be reported: we do not report "slight
ovalocytosis" or "fine basophilic stippling".
- where
red cell morphology indicates one or several likely diagnoses,
we will report the probable diagnoses along with the important
findings. However, if the specific diagnosis is certain, we will
generally not report the findings that lead to a smear
diagnosis. Thus, if the patient has sickle cells, target cells,
polychromatophilia, nucleated red cells and other inclusions we
will report "major sickling disorder", or a specific
diagnosis such as "sickle-thalassemia", if we know it,
instead of the individual findings that could lead to that conclusion.
- vague
and non-specific terms such as anisocytosis and basophilic stippling
(unless the stippling is coarse), will be avoided.
- abnormalities
already indicated by other parts of the report will not be reported:
we will not comment on red cell size, since the MCV is available;
nor will we report poikilocytosis when we can more usefully report
what the poikilocytes are, such as spherocytes or target cells.
What you should see is fewer descriptive terms on the normal differential
reports than previously. However, what is reported is likely to
be significant. An occasional diagnosis will be offered.
Peter McPhedran, M.D
|